According to Rohto Pharmaceutical's latest financial reports the company's current revenue (TTM) is $1.85 B. In 2022 the company made a revenue of $1.74 B an increase over the years 2021 revenue that were of $1.74 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $1.85 B | 6.45% |
2022 | $1.74 B | 0% |
2021 | $1.74 B | 2.75% |
2020 | $1.69 B | -0.99% |
2019 | $1.71 B | 3.53% |
2018 | $1.65 B | 11.19% |
2017 | $1.48 B | 2.4% |
2016 | $1.45 B | 6.61% |
2015 | $1.36 B | -0.29% |
2014 | $1.36 B | -2.91% |
2013 | $1.40 B | -8.19% |
2012 | $1.53 B | 1.65% |
2011 | $1.51 B | 14.69% |
2010 | $1.31 B | 11.61% |
2009 | $1.17 B |